EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synergistic Antimicrobial Activity of BrSPR20-P1 Peptide and Silver Nanoparticles Against Pathogenic Bacteria

Thanyamai Thongin, Somchai Sawatdee iD, Nuttapon Songnaka iD, Jumpei Uchiyama iD, Theanchai Wiwasuku, Teerapol Srichana iD, Titpawan Nakpheng, Apichart Atipairin iD

International Journal of Molecular Sciences · 13.08.2025 · 26 (16) · 7832

DOI: 10.3390/ijms26167832 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.08.2025. Verfasst von Thanyamai Thongin und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Walailak University, Nakhon Si Thammarat 80161, Thailand. Hauptthemen laut MEDLINE: Metal Nanoparticles, Silver, Anti-Bacterial Agents, Antimicrobial Peptides. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Walailak University, Walailak University Graduate Scholarships, Walailak University Graduate Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacterial infection is a cause of life-threatening diseases. The emergence of antimicrobial-resistant bacteria exacerbates this situation, highlighting the need for the discovery of new antimicrobial agents. Our previous study identified a novel antimicrobial peptide, BrSPR20-P1 (P1), which showed potential activity against MRSA. Additionally, silver nanoparticles (AgNPs) exhibit broad-spectrum antibacterial activity, capable of killing multidrug-resistant bacteria. The combination of antimicrobial agents presents a novel strategy for combating these pathogens. This study aimed to evaluate the antibacterial activity of the combination of P1 and AgNPs. It revealed that the combinations showed synergy. The P1 and AgNP mixture at a concentration of 1 and 8 µg/mL (1:8) doubled the activity against S. aureus and MRSA, while that combination of 64 and 64 µg/mL (64:64) exhibited broad-spectrum activity, expanding to E. coli with a 32-fold increase. These combinations exhibited a bactericidal effect, showing the rapid killing of tested bacteria at 10× MIC, with killing rates during the first 3 h ranging from 4.04 ± 0.01 to 4.31 ± 0.03 h−1. The P1 and AgNP mixtures caused a low risk of antibacterial resistance up to 30 passages. It was demonstrated that the synergistic activity of P1 and AgNPs occurred through the disruption of cell walls and membranes, leakage of intracellular materials, and cell lysis. Additionally, the mixtures appeared to interact with bacterial genomic DNA, as indicated by a gel retardation assay. These activities of the combinations were concentration-dependent. The 1:8 µg/mL mixture caused low hemolysis and cytotoxicity and did not impede the wound healing process. In contrast, although the 64:64 µg/mL mixture showed excellent antibacterial efficacy, it was toxic to erythrocytes and mammalian cells. It implies that dose optimization is required to balance its efficacy and toxicity. Therefore, the P1 and AgNP combinations exhibit synergistic antimicrobial activity and have the potential to resolve bacterial infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metal NanoparticlesSilverAnti-Bacterial AgentsAntimicrobial PeptidesAntimicrobial Cationic PeptidesDrug SynergismMicrobial Sensitivity TestsHumansEscherichia coliMethicillin-Resistant Staphylococcus aureusStaphylococcus aureus

Stichwörter der Autor:innen

Brevibacillus sp. SPR20antimicrobial peptidesilver nanoparticlesynergistic effect

Substanzen

SilverAnti-Bacterial AgentsAntimicrobial PeptidesAntimicrobial Cationic Peptides

Autor:innen und Institutionen

  • School of Pharmacy, Walailak University, Nakhon Si Thammarat 80161, Thailand.
  • Drug and Cosmetic Excellence Center, Walailak University, Nakhon Si Thammarat 80161, Thailand.
  • Department of Bacteriology, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama 700-8558, Japan.
  • School of Science, Walailak University, Thasala, Nakhon Si Thammarat 80161, Thailand.
  • Drug Delivery System Excellence Center and Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat Yai 90112, Thailand.

ORCID-Profile: Somchai Sawatdee, Nuttapon Songnaka, Jumpei Uchiyama, Teerapol Srichana, Apichart Atipairin

Förderung

  • Walailak University
  • Walailak University Graduate Scholarships
  • Walailak University Graduate Research Fund
  • Scholarships for High Potential Candidates to Enroll in Master Programs, Walailak University
  • King Prajadhipok and Queen Rambhai Barni Memorial Foundation
  • Walailak University, Scholarships for High Potential Candidates to Enroll in Master Programs

Zitieren

APA

Thongin, T., Sawatdee, S., Songnaka, N., Uchiyama, J., Wiwasuku, T., Srichana, T., Nakpheng, T., & Atipairin, A. (2025). Synergistic Antimicrobial Activity of BrSPR20-P1 Peptide and Silver Nanoparticles Against Pathogenic Bacteria. International Journal of Molecular Sciences, 26(16), 7832. https://doi.org/10.3390/ijms26167832

Vancouver

Thongin T, Sawatdee S, Songnaka N, Uchiyama J, Wiwasuku T, Srichana T, et al. Synergistic Antimicrobial Activity of BrSPR20-P1 Peptide and Silver Nanoparticles Against Pathogenic Bacteria. International Journal of Molecular Sciences. 2025;26(16):7832. doi:10.3390/ijms26167832

BibTeX
@article{Thongin2025,
  author = {Thongin, Thanyamai and Sawatdee, Somchai and Songnaka, Nuttapon and Uchiyama, Jumpei and Wiwasuku, Theanchai and Srichana, Teerapol and Nakpheng, Titpawan and Atipairin, Apichart},
  title = {Synergistic Antimicrobial Activity of BrSPR20-P1 Peptide and Silver Nanoparticles Against Pathogenic Bacteria},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {16},
  pages = {7832},
  doi = {10.3390/ijms26167832}
}
Kostenlos starten →